Postmenopausal estrogen and progestin use in relation to breast cancer risk.
about
Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtypeProgesterone receptors--animal models and cell signalling in breast cancer. Implications for breast cancer of inclusion of progestins in hormone replacement therapiesBody mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor statusImproving the management of people with a family history of breast cancer in primary care: before and after study of audit-based educationGenetic variation in the progesterone receptor and metabolism pathways and hormone therapy in relation to breast cancer riskSex hormones and the risk of keratinocyte cancers among women in the United States: A population-based case-control study.Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55-74 years of ageChange in lifestyle behaviors and medication use after a diagnosis of ductal carcinoma in situ.Menopausal hormone therapy and subsequent risk of specific invasive breast cancer subtypes in the California Teachers Study.Late age at first full term birth is strongly associated with lobular breast cancer.Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study.The contribution of postmenopausal hormone use cessation to the declining incidence of breast cancer.Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort studyUrban-rural disparity of breast cancer and socioeconomic risk factors in ChinaLobular breast cancer: incidence and genetic and non-genetic risk factors.Breast cancer risk factors in relation to breast density (United States).Hormone therapy and young-onset breast cancer.Postmenopausal hormone therapy and breast cancer: a systematic review and meta-analysisOral progestagens before menopause and breast cancer risk.Postoophorectomy estrogen use and breast cancer risk.Alcohol and breast cancer tumor subtypes in a Spanish Cohort.Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer.Established breast cancer risk factors by clinically important tumour characteristics.Clinical characteristics of different histologic types of breast cancer.An overview of menopausal oestrogen-progestin hormone therapy and breast cancer risk.Current breast cancer risks of hormone replacement therapy in postmenopausal women.Alcohol consumption and breast cancer risk among postmenopausal women following the cessation of hormone therapy use: the California Teachers StudyBreast cancer risk factors in Turkish women--a University Hospital based nested case control studyA genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication.Menopausal hormone therapy and breast cancer: what is the true size of the increased risk?Menopausal hormone therapy and breast cancer risk in the NIH-AARP Diet and Health Study Cohort.Prediagnostic use of hormone therapy and mortality after breast cancer.Pre-diagnosis oophorectomy, estrogen therapy and mortality in a cohort of women diagnosed with breast cancerEtiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation.Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort.E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium.
P2860
Q21195226-52F664B9-50DC-45CE-9037-5D4FCA9C0DE4Q24800282-3C32021B-C39C-415E-A35D-5F2EE4C56D5FQ27012792-200D4C4A-8C1C-4ABB-A2E4-F8F53A9E3973Q28386892-77AAF9B8-F617-4856-ADE6-60C2E9272855Q30491822-A36D4D00-64F7-47E3-B964-71F44104F8FDQ33657348-6E8B5371-BE0A-40A8-81C8-5313CD02156EQ33823771-27AD48D2-8D01-4044-A5CC-0AB94F6D533DQ34077062-6920E93A-5C20-42CF-8BA3-D4427FDB026AQ34115930-C29FE8F9-6D50-4BC4-BE73-DAC06AAD0BA9Q34179808-04E45FE8-0AFF-45FD-9CFE-216AC1222E25Q34420425-771AC4CE-BA3C-4545-B9FD-6BE5B3099BAFQ34480625-42297C39-2CCE-47EF-B055-3F8286DB1A19Q34555256-A55954EA-BA4B-4E38-8E25-CAB278B165C0Q34576753-FF035497-B4AF-429E-B1A6-C0F864073E42Q35092398-1E250445-A5C3-475B-921A-1403B1BFF347Q35170028-7DE58F18-4063-4BBB-B480-CCF2F54216D8Q35230186-E4966490-BE65-45AA-A110-5DD0156125B1Q35580329-2E7B81CD-48C6-4924-B10C-0B3615E064C9Q35608346-C87E859F-7F4A-411D-A4FD-308EB041B5C9Q36113902-4C4FF573-51E2-4460-B3AE-F3B4F3ACF5E5Q36188676-0353DA4F-0E00-4AF8-A888-A2BA3422289DQ36468547-34369C18-ED3A-46F7-A94D-D998048024D9Q36593545-62D4345A-1B25-41AC-A2E6-612D831E5283Q36611606-FEB2C48C-DD3B-4C07-8820-337301E762CAQ36615540-7A0BF089-3916-499C-BF09-480D80298D04Q36615906-F8907DB9-B58A-4521-8134-9EB59C5EA3C7Q36675379-20D2C555-8956-4FED-B401-CF6D3BACB0BBQ37041238-81F8881B-5AC0-4306-A0CC-7DC173808072Q37182179-34F1D5DA-FB72-4379-8755-FAF3169B25D6Q37192589-81A5AC26-5D57-462B-BC47-D20B197FF448Q37203133-9A0903CD-4E2D-4D71-AC8E-2FF20AA875E6Q37370478-E74919B7-ACD1-4214-AE28-3AA1C92FDFDEQ37428023-CEAC56EA-5B5D-4E11-9539-13C5F13A19E4Q37690142-A53A9A18-E0E3-48FF-AAE6-FFD12B898573Q51766497-F96DB463-97FA-4CA7-8035-6CCA1C62FB3FQ54110608-1396BCF8-A4AA-4127-BBD4-C29962B7FC50Q55110745-C6890ACC-35A1-4C39-9AEB-94AE0F3D8CEA
P2860
Postmenopausal estrogen and progestin use in relation to breast cancer risk.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Postmenopausal estrogen and progestin use in relation to breast cancer risk.
@ast
Postmenopausal estrogen and progestin use in relation to breast cancer risk.
@en
Postmenopausal estrogen and progestin use in relation to breast cancer risk.
@nl
type
label
Postmenopausal estrogen and progestin use in relation to breast cancer risk.
@ast
Postmenopausal estrogen and progestin use in relation to breast cancer risk.
@en
Postmenopausal estrogen and progestin use in relation to breast cancer risk.
@nl
prefLabel
Postmenopausal estrogen and progestin use in relation to breast cancer risk.
@ast
Postmenopausal estrogen and progestin use in relation to breast cancer risk.
@en
Postmenopausal estrogen and progestin use in relation to breast cancer risk.
@nl
P2093
P50
P1476
Postmenopausal estrogen and progestin use in relation to breast cancer risk.
@en
P2093
Amy Trentham-Dietz
John A Baron
Kathleen M Egan
Linda Titus-Ernstoff
P304
P577
2002-07-01T00:00:00Z